Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

"> 回首頁LOGO按鈕

繁簡 EN

最新消息

News & Message

:::

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

最新消息

2026/2/3

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

側邊開關圖示

中國醫點通

百度搜狗 360搜索央行：下周将有7634亿逆回购到期何济霆赌博安徽淮北：非遗传承人巧手塑泥人再现淮海战役军民同心历史景象美国一飞机遭激光照射女生遭性侵轻生舍友忆惊魂夜

<code id='cf069'></code><style id='65df7'></style>

<acronym id='8c8d3'></acronym>

<center id='62178'><center id='eabf1'><tfoot id='937b9'></tfoot></center><abbr id='1cbae'><dir id='9c757'><tfoot id='ec70e'></tfoot><noframes id='b0fd2'>

<optgroup id='f9c07'><strike id='72304'><sup id='73bb3'></sup></strike><code id='1450c'></code></optgroup>

<b id='d00e7'><label id='5df2a'><select id='68a73'><dt id='275d0'><span id='d9dcc'></span></dt></select></label></b><u id='410ab'></u>

~~<i id='12f75'><strike id='8dd32'><tt id='2c503'><pre id='5b7b1'></pre></tt></strike></i>~~